BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 4382437)

  • 1. Steroidal monoquaternary ammonium salts with non-depolarizing neuromuscular blocking activity.
    Lewis JJ; Martin-Smith M; Muir TC; Ross HH
    J Pharm Pharmacol; 1967 Aug; 19(8):502-8. PubMed ID: 4382437
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison between the effects of tetraethylammonium and triethyl-(3-hydroxyphenyl)ammonium on frog neuromuscular transmission.
    Kuperman AS; Okamoto M
    Br J Pharmacol Chemother; 1966 Jan; 26(1):218-28. PubMed ID: 5919505
    [No Abstract]   [Full Text] [Related]  

  • 3. On the role of the ester groups in the internitrogen chain in the action of bisquaternary compounds on skeletal muscles.
    Danilov AF; Guli-Kevkhyan RS; Lavrentieva VV; Michelson MJ; Mndjoyan OL; Shelkovnikov SA; Starshinova LA
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):35-51. PubMed ID: 4844369
    [No Abstract]   [Full Text] [Related]  

  • 4. Ganglion-blocking, neuromuscular-blocking and other actions of 2-imino-4-ethyloxycarbonyl-1,3-diazacycloheptane hydrochloride (OG 30), a ganglionic stimulant.
    Saxena PR
    Eur J Pharmacol; 1970 Jul; 11(1):75-83. PubMed ID: 4317241
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of a negative quaternary ion-sodium tetraphenylboron (TPB) on the rat phrenic nerve-diaphragm preparation.
    Guideri G; Seifter E; Seifter J
    Eur J Pharmacol; 1972 Feb; 17(2):253-8. PubMed ID: 4537254
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuromuscular blocking activity and other pharmacologic properties of various carnitine derivatives.
    Hosein EA; Booth SJ; Gasoi I; Kato G
    J Pharmacol Exp Ther; 1967 Jun; 156(3):565-72. PubMed ID: 6028881
    [No Abstract]   [Full Text] [Related]  

  • 7. Interactions of serotonin with neuromuscular blocking agents.
    Dretchen K; Ghoneim MM; Long JP
    Eur J Pharmacol; 1972 Apr; 18(1):121-7. PubMed ID: 4260607
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacodynamic evaluation of a new synthetic curare-like agent: acetylenic-gallamine].
    Cloutier G; Goyer GR; Bolduc R; Salvador RL
    Arch Int Pharmacodyn Ther; 1970 Mar; 184(1):75-92. PubMed ID: 4247340
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuromuscular pharmacology of oxotremorine.
    Ganguly DK; Chaudhuri SK
    Eur J Pharmacol; 1970 Jul; 11(1):84-9. PubMed ID: 5431117
    [No Abstract]   [Full Text] [Related]  

  • 10. The pharmacological effects of selectively released hydrogen cyanide.
    Jaramillo J; Haarstad VB
    Eur J Pharmacol; 1969 Oct; 8(1):127-45. PubMed ID: 5357070
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuromuscular blocking actions of nereistoxin and its derivatives and antagonism by sulfhydryl compounds.
    Nagawa Y; Saji Y; Chiba S; Yui T
    Jpn J Pharmacol; 1971 Apr; 21(2):185-97. PubMed ID: 4325625
    [No Abstract]   [Full Text] [Related]  

  • 12. Facilitatory drug action on the isolated phrenic nerve-diaphragm preparation of the rat.
    Freeman SE; Turner RJ
    J Pharmacol Exp Ther; 1970 Sep; 174(3):550-9. PubMed ID: 4318490
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuromuscular blocking properties of stereoisomeric androstane-3,l7-bisquaternary ammonium salts.
    Bamford DG; Biggs DF; Davis M; Parnell EW
    Br J Pharmacol Chemother; 1967 May; 30(1):194-202. PubMed ID: 4962751
    [No Abstract]   [Full Text] [Related]  

  • 14. Quillaiate of choline iodide: a new monoquaternary neuromuscular blocking agent.
    Hamed MI; el-Gholmy Z
    Arzneimittelforschung; 1972 Dec; 22(12):2133-6. PubMed ID: 4350747
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of emetine on neuromuscular transmission.
    Salako LA
    Eur J Pharmacol; 1970; 11(3):342-8. PubMed ID: 4320090
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening of some basic amides for local anaesthetic and neuromuscular blocking activity.
    Derasari HR; Patel MN
    Indian J Physiol Pharmacol; 1973; 17(1):55-62. PubMed ID: 4270899
    [No Abstract]   [Full Text] [Related]  

  • 17. The rate of action of competitive neuromuscular blocking agents.
    Waud DR
    J Pharmacol Exp Ther; 1967 Oct; 158(1):99-114. PubMed ID: 6054082
    [No Abstract]   [Full Text] [Related]  

  • 18. Two new short-acting non-depolarizing neuromuscular blocking agents.
    Copp FC; Coker GG; Green AF; Hughes R; Nimmo-Smith RH
    Experientia; 1972 Jan; 28(1):47-8. PubMed ID: 4259013
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuromuscular blocking agents: branched-chain tetra-onium compounds.
    Edwards D; Lewis JJ; Marren G
    J Pharm Pharmacol; 1966 Oct; 18(10):670-6. PubMed ID: 4382075
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of (+)-tubocurarine on neuromuscular facilitation and depression in rat diaphragm.
    Hinman DJ; Jacobs RS; Karczmar AG
    Neuropharmacology; 1976 Jul; 15(7):427-32. PubMed ID: 185539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.